Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
420 questions in 57 reviews · Gut
current versionsNo studies 420 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Web‐based patient education vs other delivery of patient education Flare‐ups or relapse (continuous) · people with inflammatory bowel disease Patient education interventions for the management of inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based patient education vs other delivery of patient education Flare‐ups or relapse (dichotomous) · people with inflammatory bowel disease Patient education interventions for the management of inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy manual and telephone support vs usual care Disease activity · people with inflammatory bowel disease Remote care through telehealth for people with inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy manual and telephone support vs usual care Flare‐ups/relapse · people with inflammatory bowel disease Remote care through telehealth for people with inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy manual and telephone support vs usual care Quality of life · people with inflammatory bowel disease Remote care through telehealth for people with inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based disease monitoring vs sham monitoring Disease activity · people with inflammatory bowel disease Remote care through telehealth for people with inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Web‐based disease monitoring vs sham monitoring Flare‐ups/relapse · people with inflammatory bowel disease Remote care through telehealth for people with inflammatory bowel disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Tacrolimus vs ciclosporin Serious adverse events · adults with refractory, moderate‐to‐severe ulcerative colitis Tacrolimus (FK506) for induction of remission in corticosteroid‐refractory ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
Tacrolimus vs ciclosporin Total adverse events · adults with refractory, moderate‐to‐severe ulcerative colitis Tacrolimus (FK506) for induction of remission in corticosteroid‐refractory ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
LHC + Dor vs LHC + angle of His accentuation Postoperative pathological acid reflux · adult patients (> 18 years) with achalasia Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia (2022) · Cochrane | no estimate extracted | NR | No studies |
Duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart technique vs duct‐to‐mucosa pancreaticojejunostomy using the traditional interrupted technique Adverse events · adults undergoing open pancreaticoduodenectomy Duct‐to‐mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic… (2022) · Cochrane | no estimate extracted | NR | No studies |
Duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart technique vs duct‐to‐mucosa pancreaticojejunostomy using the traditional interrupted technique Quality of life · adults undergoing open pancreaticoduodenectomy Duct‐to‐mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic… (2022) · Cochrane | no estimate extracted | NR | No studies |
Duct‐to‐mucosa vs invagination pancreaticojejunostomy Adverse events · adults undergoing open pancreaticoduodenectomy Duct‐to‐mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic… (2022) · Cochrane | no estimate extracted | NR | No studies |
Duct‐to‐mucosa vs invagination pancreaticojejunostomy Quality of life · adults undergoing open pancreaticoduodenectomy Duct‐to‐mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic… (2022) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs probiotics Failure to induce clinical response at end of study · people with active UC Antibiotics for the induction and maintenance of remission in ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs 5‐ASA Failure to maintain clinical response at end of study · people with UC in remission Antibiotics for the induction and maintenance of remission in ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Failure to induce clinical response at end of study · of active and inactive people with ulcerative colitis Antibiotics for the induction and maintenance of remission in ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics plus probiotics vs placebo or no intervention Failure to induce clinical response at end of study · people with active UC Antibiotics for the induction and maintenance of remission in ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs 5‐ASA Failure to induce clinical remission at end of study · people with active UC Antibiotics for the induction and maintenance of remission in ulcerative colitis (2022) · Cochrane | no estimate extracted | NR | No studies |
Synbiotics vs placebo Frequency of defecation (number of stools/week at end of study) · children with chronic constipation without a physical explanation Probiotics for treatment of chronic constipation in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Early vs late drain removal following pancreatic surgery Mortality · people undergoing elective pancreatic resections Prophylactic abdominal drainage for pancreatic surgery (2021) · Cochrane | no estimate extracted | NR | No studies |
Early vs late drain removal following pancreatic surgery Drain‐related complications · people undergoing elective pancreatic resections Prophylactic abdominal drainage for pancreatic surgery (2021) · Cochrane | no estimate extracted | NR | No studies |
Active drain vs passive drain following pancreatic surgery Mortality · people undergoing elective pancreatic resections Prophylactic abdominal drainage for pancreatic surgery (2021) · Cochrane | no estimate extracted | NR | No studies |
Returning vs discarding the aspirated/drained gastric residual volume Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube Monitoring of gastric residual volume during enteral nutrition (2021) · Cochrane | no estimate extracted | NR | No studies |
Returning vs discarding the aspirated/drained gastric residual volume Pneumonia (at the end of · adults receiving EN via nasogastric or gastrostomy tube Monitoring of gastric residual volume during enteral nutrition (2021) · Cochrane | no estimate extracted | NR | No studies |
Returning vs discarding the aspirated/drained gastric residual volume Length of hospital stay (days) (at the end of · adults receiving EN via nasogastric or gastrostomy tube Monitoring of gastric residual volume during enteral nutrition (2021) · Cochrane | no estimate extracted | NR | No studies |
IM erythropoietin vs oral placebo Serious adverse events · IBD patients Interventions for treating iron deficiency anaemia in inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Low FODMAP diet vs sham diet Treatment success as defined by the authors · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Medicine‐separated moxibustion combined with acupuncture vs wheat bran‐separated moxibustion combined with shallow acupuncture Abdominal pain frequency or change in frequency · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Medicine‐separated moxibustion combined with acupuncture vs wheat bran‐separated moxibustion combined with shallow acupuncture Abdominal pain intensity or change in intensity · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Mindfulness with cognitive behavioural therapy (CBT) vs no treatment (both groups received standard medical therapy) Treatment success as defined by the authors · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
soft non‐manipulative osteopathic treatment vs no intervention Treatment success as defined by the authors · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
soft non‐manipulative osteopathic treatment vs no intervention Abdominal pain frequency or change in frequency · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs standard treatment Treatment success as defined by the authors · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs standard treatment Pain frequency or change in pain frequency · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs standard treatment Withdrawals due to adverse events · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Self‐directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs standard treatment Treatment success as defined by the authors · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Self‐directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs standard treatment Pain frequency or change in pain frequency · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Self‐directed stress management (it is unclear whether these interventions replaced standard treatment or were added to standard treatment) vs standard treatment Withdrawals due to adverse events · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Enteric‐release glyceryl trinitrate vs placebo Treatment success as defined by the authors · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Enteric‐release glyceryl trinitrate vs placebo Abdominal pain frequency or change in frequency · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Enteric‐release glyceryl trinitrate vs placebo Abdominal pain intensity or change in intensity · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
100 mg olorinab 3 times/day vs 25 mg olorinab 3 times/day Treatment success as defined by the authors · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
100 mg olorinab 3 times/day vs 25 mg olorinab 3 times/day Pain frequency or change in pain frequency · people with Crohn's disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Relaxation training vs waitlist Treatment success as defined by the authors · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Relaxation training vs waitlist Pain frequency or change in pain frequency · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Relaxation training vs waitlist Withdrawals due to adverse effects · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Web‐based education vs standard book‐based education Treatment success as defined by the authors · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Web‐based education vs standard book‐based education Abdominal pain frequency or change in frequency · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Yoga intervention vs no treatment (both groups received standard medical therapy) Treatment success as defined by the authors · people with inflammatory bowel disease Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease (2021) · Cochrane | no estimate extracted | NR | No studies |